Mon­i­tor­ing brain­waves via dreem wer­able device (Qan­tas)

_______________

Qan­tas’ first 19.5‑hour research flight from New York to Syd­ney takes off (Nine News):

“Qan­tas CEO Alan Joyce, who today is in New York for the research flight, told Today Show via a live cross that he will be select­ing an air­craft for the mam­moth job by the year’s end, in line with a pre­vi­ous time-line.

“The flight is going to be ground-break­ing, as you said. We’ve got 19 hours — we’ve got a lot of sci­en­tists and we’re look­ing at dif­fer­ent ways of mak­ing the oper­a­tion actu­al­ly great for our pas­sen­gers,” Joyce said. Read the rest of this entry »

_______________

This start­up just raised $8 mil­lion to help busy doc­tors assess the cog­ni­tive health of 50 mil­lion seniors (TechCrunch):

“…star­tups increas­ing­ly rec­og­nize oppor­tu­ni­ties to cater to this aging pop­u­la­tion. Some are devel­op­ing prod­ucts to sell to indi­vid­u­als and their fam­i­ly mem­bers direct­ly; oth­ers are com­ing up with ways to empow­er those who work direct­ly with old­er Amer­i­cans.

BrainCheck, a 20-per­son, Hous­ton-based start­up whose cog­ni­tive health­care prod­uct aims to help physi­cians assess and track the men­tal health of their patients, is among the lat­ter. Investors like what it has put togeth­er, too. Today, the start­up is announc­ing $8 mil­lion in Series A fund­ing co-led by S3 Ven­tures and Ten­sil­i­ty Ven­ture Part­ners. Read the rest of this entry »

_______________

Bay­er inks deals with eleven star­tups under G4A Dig­i­tal Health Part­ner­ships pro­gram (press release):

“Bay­er announced today that the com­pa­ny has signed col­lab­o­ra­tion agree­ments with eleven dig­i­tal health star­tups. As part of the pro­gram, Bay­er will sup­port these start­up com­pa­nies aim­ing for longer-term col­lab­o­ra­tions to dri­ve for­ward the devel­op­ment of spe­cif­ic dig­i­tal solu­tions to improve patients’ health Read the rest of this entry »

__________

Long-Term Fol­low-Up Data Shows Deep Brain Stim­u­la­tion Is an Effec­tive Treat­ment for Treat­ment-Resis­tant Depres­sion (Mount Sinai press release):

“A study pub­lished online on Fri­day, Octo­ber 4, in The Amer­i­can Jour­nal of Psy­chi­a­try found that deep brain stim­u­la­tion (DBS) of an area in the brain called the sub­cal­los­al cin­gu­late (SCC) pro­vides a robust anti­de­pres­sant effect that is sus­tained over a long peri­od of time in patients with treat­ment-resis­tant depres­sion Read the rest of this entry »

_______________

What: Brain­Mind is build­ing a best-in-class com­mu­ni­ty around the mis­sion to advance neu­ro­science inno­va­tion that will most ben­e­fit human­i­ty. This sum­mit will cat­alyze focused and infor­mal col­lab­o­ra­tions between sec­tor-defin­ing sci­en­tists, entre­pre­neurs, oper­a­tors, investors, lead­ers, thinkers, and phil­an­thropists. Read the rest of this entry »